657 results on '"Davis, Brian J."'
Search Results
152. Stranded Seeds and Seed Displacement as Estimated By Day 0 Fluoroscopy and Four Month Post-Implant Pelvic X-Ray
153. Prostate Brachytherapy Seed Migration To A Coronary Artery Found During Angiography
154. Mice expressing a “hyper-sensitive” form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.
155. Feasibility of vibro-acoustography with a quasi-2D ultrasound array transducer for detection and localizing of permanent prostate brachytherapy seeds: A pilot ex vivo study
156. Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’
157. ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer
158. Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice
159. Prostate Volume Before and After Neoadjuvant Cytoreductive Androgen Suppression and Potential Predictors of Cytoreductive Efficacy
160. Lawyers' negligence liability to non-clients: a Texas viewpoint.
161. Multimodality Therapy Including Surgical Resection and Intraoperative Electron Radiotherapy for Recurrent or Advanced Primary Carcinoma of the Urinary Bladder or Ureter
162. Magnetic Resonance Imaging-guided Cryoablation of Recurrent Prostate Cancer After Radical Prostatectomy: Initial Single Institution Experience
163. Vibro-acoustography with 1.75D ultrasound array transducer for detection and localization of permanent prostate brachytherapy seeds:ex vivostudy
164. Application of vibro-acoustography in prostate tissue imaging
165. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
166. Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic.
167. Progress in Gene Therapy for Prostate Cancer
168. Thomas Shanahan, MD
169. ACR Appropriateness Criteria®Locally Advanced, High-Risk Prostate Cancer
170. Massive CO 2 Ice Deposits Sequestered in the South Polar Layered Deposits of Mars
171. Multicenter Analysis of Effect of High Biologic Effective Dose on Biochemical Failure and Survival Outcomes in Patients With Gleason Score 7–10 Prostate Cancer Treated With Permanent Prostate Brachytherapy
172. In Reply to Drs. Oton and Oton
173. Estimated limits of IMRT dose escalation using varied planning target volume margins
174. A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy
175. Planning Target Margin Calculations for Prostate Radiotherapy Based on Intrafraction and Interfraction Motion Using Four Localization Methods
176. Customized Dose Prescription for Permanent Prostate Brachytherapy: Insights From a Multicenter Analysis of Dosimetry Outcomes
177. Prediction of Radial Distance of Extraprostatic Extension From Pretherapy Factors
178. Prostate brachytherapy seed reconstruction using an adaptive grouping technique
179. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry
180. Design and testing of a custom transurethral ultrasound device with rapid 3D reconstruction using a rotational scanner
181. 1763: Multicenter Analysis of Outcomes in Patients Treated with Permanent Prostate Brachytherapy: Effect of PSA Failure Definition and Dose on Biochemical Defined Relapse
182. LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer
183. Seed localization and TRUS-fluoroscopy fusion for intraoperative prostate brachytherapy dosimetry
184. NAVSUP FLC Puget Sound Hosts Washington Ferry for Fueling Exercise
185. NAVSUP FLC Puget Sound Participates in QLLEX '17
186. NAVSUP FLC Puget Sound 'Fuelies' Participate in Joint Fuel Spill Exercise
187. NAVSUP FLC Puget Sound Supports Nimitz Deployment
188. Symposium Focuses on Developing Supply Corps Officers
189. ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer.
190. Interstitial implant alone with or without external beam radiation therapy for intermediate risk localized prostate cancer: Patterns of Care Study in the United States
191. 861: Serum Human Glandular Kallikrein 2 and Pro-Human Glandular Kallikrein 2 Concentration Correlates with Survival in Patients with Hormone Refractory Prostate Cancer
192. A Preclinical Large Animal Model of Adenovirus-Mediated Expression of the Sodium–Iodide Symporter for Radioiodide Imaging and Therapy of Locally Recurrent Prostate Cancer
193. LETTER TO THE EDITOR
194. URINARY FISTULAS FOLLOWING EXTERNAL RADIATION OR PERMANENT BRACHYTHERAPY FOR THE TREATMENT OF PROSTATE CANCER
195. Prostate Volume Before and After Permanent Prostate Brachytherapy in Patients Receiving Neoadjuvant Androgen Suppression
196. Fluoroscopy to ultrasound image registration using implanted seeds as fiducials during permanent prostate brachytherapy
197. Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer
198. Seed based registration for intraoperative brachytherapy dosimetry: a comparison of methods.
199. A method for size estimation for small objects and its application in brachytherapy seed identification.
200. Transurethral ultrasound of the prostrate for applications in prostrate brachytherapy: analysis of phantom and in-vivo data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.